Parabilis Medicines, Inc. (PBLS)
39.11
-0.18
(-0.46%)
USD |
NASDAQ |
Aug 28, 16:00
39.86
+0.75
(+1.92%)
After-Hours: 20:00
Parabilis Medicines Cash from Investing (Quarterly) : -34.06M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -34.06M |
| March 31, 2026 | -0.369M |
| Date | Value |
|---|---|
| June 30, 2025 | 24.51M |
| March 31, 2025 | 6.689M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Moderna, Inc. | 329.00M |
| Kailera Therapeutics, Inc. | -571.02M |
| Arrowhead Pharmaceuticals, Inc. | 43.68M |
| Oncolytics Biotech, Inc. | 0.00 |
| Sangamo Therapeutics, Inc. | -0.013M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.622M |
| Cash from Financing (Quarterly) | 795.71M |
| Free Cash Flow | -119.14M |
| Free Cash Flow Per Share (Quarterly) | -0.0343 |
| Free Cash Flow to Equity (Quarterly) | 1.397M |
| Free Cash Flow to Firm (Quarterly) | -4.028M |
| Free Cash Flow Yield | -2.52% |